Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NAKAMURA, A.
Right arrow Articles by KOHSAKA, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NAKAMURA, A.
Right arrow Articles by KOHSAKA, T.
J Am Soc Nephrol 12:2288-2299, 2001
© 2001 American Society of Nephrology

Activation of ß2-Adrenoceptor Prevents Shiga Toxin 2-Induced TNF-{alpha} Gene Transcription

AKIO NAKAMURA*, EDWARD J. JOHNS{dagger}, AKIRA IMAIZUMI*, YUKISHIGE YANAGAWA* and TAKAO KOHSAKA{ddagger}

* Department of Paediatrics, Teikyo University School of Medicine, Tokyo, Japan
{dagger} Department of Physiology, University of Birmingham, Birmingham, United Kingdom
{ddagger} Department of Immunology, National Children's Medical Centre, Tokyo, Japan.

Correspondence to Dr. Akio Nakamura, Department of Paediatrics, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173, Japan. Phone: 03-3964-1211 (ext. 1480); Fax: 03-3579-8212; E-mail: akio{at}med.teikyo-u.ac.jp

Abstract. Exposure of renal tubular epithelial cells to shiga toxin 2 (Stx-2) causes cytotoxicity, and the potency of this toxin is enhanced in the presence of tumor necrosis factor—{alpha} (TNF-{alpha}). It has been shown that Stx-2 induces TNF-{alpha} production and that activation of ß2-adrenoceptors downregulates TNF-{alpha}. However, little is known about the signaling pathway by which ß2-adrenoceptor agonists suppress the Stx-2—induced TNF-{alpha} gene transcription. The possible signaling components involved in this pathway were investigated. Human adenocarcinoma—derived renal tubular epithelial cells (ACHN) were exposed to Stx-2 in the presence or absence of a ß2-adrenoceptor agonist. Mitogen-activated protein kinase (MAPK), activating protein—1 (AP-1), and nuclear factor—{kappa}B (NF-{kappa}B) were measured to evaluate the regulatory mechanisms involved in TNF-{alpha} gene transcription. Stx-2 (4 pg/ml) stimulated MAPK (p42/p44, p38) and AP-1 and increased TNF-{alpha} promoter activity by 2.4-fold. The increase in TNF-{alpha} was attenuated by both a p42/p44 inhibitor, PD098059 (10-6 M), and a p38 inhibitor, SB203580 (10-6 M), and AP-1—binding activity was inhibited by PD098059. Terbutaline (10-6 M to 10-8 M) suppressed MAPK (p42/p44, p38), NF-{kappa}B (p50, p65), and TNF-{alpha} promoter activity in a dose-dependent way that was prevented by the ß2-adrenoceptor antagonist, ICI118,551. However, inhibition of MAPK (p42/p44) and TNF-{alpha} promoter activity was partially prevented by the cAMP-protein kinase (PKA) inhibitors, H-89 (5 x 10-6 M) and KT5720 (10-5 M), whereas the suppression of p38 MAPK or NF-{kappa}B (p50) was not blocked by these inhibitors. The suppression of NF-{kappa}B (p65) was completely overcome by H-89 or KT5720. In summary, the downregulation of TNF-{alpha} transcription by terbutaline was mediated by an inhibitory effect of ß2-adrenoceptor activation on MAPK (p42/p44, p38) and NF-{kappa}B (p50/p65), which were exerted through a cAMP-PKA pathway and a cAMP-independent mechanism. It is likely that cAMP-PKA and MAPK (p42/p44, p38) may play a critical role in the regulation of the Stx-2—induced TNF-{alpha} transcription via ß2-adrenoceptor activation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Zanchi, C. Zoja, M. Morigi, F. Valsecchi, X. Y. Liu, D. Rottoli, M. Locatelli, S. Buelli, A. Pezzotta, P. Mapelli, et al.
Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin
J. Immunol., July 15, 2008; 181(2): 1460 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja
Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling
Am. J. Pathol., December 1, 2006; 169(6): 1965 - 1975.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Nakamura, A. Imaizumi, Y. Yanagawa, T. Kohsaka, and E. J. Johns
{beta}2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 316 - 325.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. E. Smith, A. V. Kane, S. T. Campbell, D. W. K. Acheson, B. H. Cochran, and C. M. Thorpe
Shiga Toxin 1 Triggers a Ribotoxic Stress Response Leading to p38 and JNK Activation and Induction of Apoptosis in Intestinal Epithelial Cells
Infect. Immun., March 1, 2003; 71(3): 1497 - 1504.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. I. Tarr
Basic Fibroblast Growth Factor and Shiga Toxin-O157:H7-Associated Hemolytic Uremic Syndrome
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 817 - 820.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP